Related Experiment Video
Updated: Jun 5, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
PPB-Affinity: Protein-Protein Binding Affinity dataset for AI-based protein drug discovery
Huaqing Liu1, Peiyi Chen1, Xiaochen Zhai2
1Artificial Intelligence Innovation Center, Research Institute of Tsinghua, Pearl River Delta, Guangzhou, 510700, China.
Researchers created the largest public protein-protein binding (PPB) affinity dataset to aid drug discovery. This dataset and a benchmark deep learning model will accelerate the screening of large-molecule drugs.
Area of Science:
- Biochemistry
- Computational Biology
- Drug Discovery
Background:
- Protein-protein binding (PPB) affinity prediction is crucial for large-molecule drug discovery.
- Deep learning models exist for predicting affinity changes due to mutations, but not for predicting absolute PPB affinity.
- A lack of publicly available datasets hinders research in predicting PPB affinity.
Purpose of the Study:
- To introduce a comprehensive, large-scale, publicly available dataset for protein-protein binding affinity (PPB-Affinity).
- To address the scarcity of data for predicting PPB affinity.
- To facilitate advancements in large-molecule drug discovery and screening.
Main Methods:
- Compilation of a novel dataset (PPB-Affinity) containing protein-protein complex crystal structures, mutation data, and binding affinities.
- Inclusion of detailed information on receptor and ligand protein chains.
- Development of a deep learning benchmark model utilizing the PPB-Affinity dataset.
Main Results:
- Creation of the largest publicly available dataset specifically for protein-protein binding affinity.
- The PPB-Affinity dataset includes structural and affinity data for protein complexes.
- A deep learning benchmark model was established for PPB affinity prediction.
Conclusions:
- The PPB-Affinity dataset represents a significant resource for the research community.
- This dataset is expected to accelerate the screening of potential large-molecule drugs.
- The benchmark model provides a foundation for future research in PPB affinity prediction.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Protein-protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...